Hellström-Lindberg, E: search on Z-Library

The world's largest scientific articles store. 70,000,000+ articles for free.

Don't use scam websites

1

The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes

Vardiman, J. W., Thiele, J., Arber, D. A., Brunning, R. D., Borowitz, M. J., Porwit, A., Harris, N. L., Le Beau, M. M., Hellstrom-Lindberg, E., Tefferi, A., Bloomfield, C. D.

Journal:

Year:

2009

Language:

english

File:

PDF, 281 KB

english, 2009

2

Peripheral blood neutrophil morphology reflects bone marrow dysplasia in myelodysplastic syndromes

S. Widell, E. Hellström-Lindberg, Y. Kock, M. Lindberg, Å. Öst, Dr. R. Hast

Journal:

American Journal of Hematology

Year:

1995

Language:

english

File:

PDF, 500 KB

english, 1995

3

Cobalt release from glazed earthenware: Observations in a case of lead poisoning

Anders I. Seldén, Carin Norberg, Christine Karlson-Stiber, Eva Hellström-Lindberg

Journal:

Environmental Toxicology and Pharmacology

Year:

2007

Language:

english

File:

PDF, 134 KB

english, 2007

4

Somatic SF3B1 Mutation in Myelodysplasia with Ring Sideroblasts

Papaemmanuil, E., Cazzola, M., Boultwood, J., Malcovati, L., Vyas, P., Bowen, D., Pellagatti, A., Wainscoat, J.S., Hellstrom-Lindberg, E., Gambacorti-Passerini, C., Godfrey, A.L., Rapado, I., Cvejic,

Journal:

Boston Medical and Surgical Journal

Year:

2011

Language:

english

File:

PDF, 865 KB

english, 2011

5

A pilot phase I dose finding safety study of the thrombopoietin-receptor agonist, eltrombopag, in patients with myelodysplastic syndrome treated with azacitidine

Svensson, Tobias, Chowdhury, Onima, Garelius, Hege, Lorenz, Fryderyk, Saft, Leonie, Jacobsen, Sten-Eirik, Hellström-Lindberg, Eva, Cherif, Honar

Journal:

European Journal of Haematology

Year:

2014

Language:

english

File:

PDF, 358 KB

english, 2014

6

Diagnosis and classification of myelodysplastic syndrome: International Working Group on Morphology of myelodysplastic syndrome (IWGM-MDS) consensus proposals for the definition and enumeration of myeloblasts and ring sideroblasts

Mufti, G. J., Bennett, J. M., Goasguen, J., Bain, B. J., Baumann, I., Brunning, R., Cazzola, M., Fenaux, P., Germing, U., Hellstrom-Lindberg, E., Jinnai, I., Manabe, A., Matsuda, A., Niemeyer, C. M.,

Journal:

Year:

2008

Language:

english

File:

PDF, 185 KB

english, 2008

7

Ex Vivo Expanded Adaptive NK Cells Effectively Kill Primary Acute Lymphoblastic Leukemia Cells

Liu, Lisa L, Beziat, Vivien, Sheng, Vincent Oei Yi, Pfefferle, Aline, Schaffer, Marie, Lehmann, Soren, Hellstrom-Lindberg, Eva, Soderhall, Stefan, Heyman, Mats, Grander, Dan, Malmberg, Karl-Johan

Journal:

Cancer Immunology Research

Year:

2017

Language:

english

File:

PDF, 4.51 MB

english, 2017

8

Cost Effectiveness of Lenalidomide in the Treatment of Transfusion-Dependent Myelodysplastic Syndromes in the United States

Goss, Thomas F., Szende, Agota, Schaefer, Caroline, Totten, P. Jane, Knight, Robert, Jädersten, Martin, Hellström-Lindberg, Eva, List, Alan F.

Journal:

Year:

2006

Language:

english

File:

PDF, 430 KB

english, 2006

9

Recombinant human granulocyte-macrophage colony-stimulating factor plus recombinant human erythropoietin may improve anemia in selected patients with myelodysplastic syndromes

Dr. Per Boye Hansen, Hans E. Johnsen, Erik Hippe, Eva Hellström-Lindberg, Elisabeth Ralfkiaer

Journal:

American Journal of Hematology

Year:

1993

Language:

english

File:

PDF, 720 KB

english, 1993

10

Continued azacitidine therapy beyond time of first response improves quality of response in patients with higher-risk myelodysplastic syndromes

Lewis R. Silverman, Pierre Fenaux, Ghulam J. Mufti, Valeria Santini, Eva Hellström-Lindberg, Norbert Gattermann, Guillermo Sanz, Alan F. List, Steven D. Gore, John F. Seymour

Journal:

Year:

2011

Language:

english

File:

PDF, 177 KB

english, 2011

11

Supportive care, growth factors, and new therapies in myelodysplastic syndromes

Eva Hellström-Lindberg, Luca Malcovati

Journal:

Year:

2008

Language:

english

File:

PDF, 245 KB

english, 2008

12

Significance of JAK2 and TET2 mutations in myelodysplastic syndromes

Eva Hellström-Lindberg

Journal:

Year:

2010

Language:

english

File:

PDF, 303 KB

english, 2010

13

Effects of azacitidine compared with conventional care regimens in elderly (≥75 years) patients with higher-risk myelodysplastic syndromes

John F. Seymour, Pierre Fenaux, Lewis R. Silverman, Ghulam J. Mufti, Eva Hellström-Lindberg, Valeria Santini, Alan F. List, Steven D. Gore, Jay Backstrom, David McKenzie, C.L. Beach

Journal:

Critical Reviews in Oncology/Hematology

Year:

2010

Language:

english

File:

PDF, 332 KB

english, 2010

14

Angiogenesis in relation to clinical stage, apoptosis and prognostic score in myelodysplastic syndromes

Lars Göran Lundberg, Eva Hellström-Lindberg, Lena Kanter-Lewensohn, Richard Lerner, Jan Palmblad

Journal:

Leukemia Research

Year:

2006

Language:

english

File:

PDF, 193 KB

english, 2006

15

Practical use of azacitidine in higher-risk myelodysplastic syndromes: An expert panel opinion

Pierre Fenaux, David Bowen, Norbert Gattermann, Eva Hellström-Lindberg, Wolf-Karsten Hofmann, Michael Pfeilstöcker, Guillermo Sanz, Valeria Santini

Journal:

Leukemia Research

Year:

2010

Language:

english

File:

PDF, 159 KB

english, 2010

16

O-17 Thalidomide analogue CC5013 (revlimid) selectively inhibits in vitro growth of the malignant clone in myelodysplastic syndrome (MDS) patients with 5Q deletion

M. Jadersten, A.-M. Forsblom, E.K. Emanuelsson, M. Merup, E. Hellström-Lindberg

Journal:

Leukemia Research

Year:

2005

Language:

english

File:

PDF, 80 KB

english, 2005

17

P-18 A new prognostic score foroutcome of patients with high-risk myelodysplastic syndrome (MDS) or secondary acute myeloid leukemia (SAML) after intensive antileukemic treatment

M. Oosterveld, S. Suciu, J.P. Marie, A. Ferrant, P. Muus, M. Delforge, E. Hellstrom-Lindberg, S. Amadori, F. Beeldens, R. Willemze, T.M. De Witte

Journal:

Leukemia Research

Year:

2005

Language:

english

File:

PDF, 79 KB

english, 2005

18

P-41 Aberrant mitochondrial iron distribution and maturation arrest characterizes early erythroid precursors in low-risk myelodysplastic syndromes

R. Tehranchi, R. Invernizzi, A. Grandien, B. Zhivotovsky, B. Fadeel, A.-M. Forsblom, E. Travaglino, J. Samuelsson, M. Cazzola, R. Wibom, E. Hellström-Lindberg

Journal:

Leukemia Research

Year:

2005

Language:

english

File:

PDF, 79 KB

english, 2005

19

P-106 Pharmacodynamic study of 5-azacytidine

R. Khan, A. Aggerholm, P. Hokland, M. Hassan, E. Hellström-Lindberg

Journal:

Leukemia Research

Year:

2005

Language:

english

File:

PDF, 78 KB

english, 2005

20

29 Treatment of myelodysplastic syndromes with erythropoietin and G-CSF

E. Hellstrom-Lindberg

Journal:

Leukemia Research

Year:

2007

Language:

english

File:

PDF, 44 KB

english, 2007

21

C023 Expression profiling of CD34+ cells in patients with myelodysplastic syndromes: differences between early and advanced cases and analysis of apoptosis-related genes

A. Pellagatti, M. Cazzola, A. Giagounidis, L. Malcovati, M.G. Della Porta, M. Jädersten, S. Killick, C. Fidler, H. Cattan, D. Bowen, C. Aul, E. Hellström-Lindberg, J.S. Wainscoat, J. Boultwood

Journal:

Leukemia Research

Year:

2007

Language:

english

File:

PDF, 52 KB

english, 2007

22

P040 Hypomethylation and apoptosis in 5-azacytidine treated myeloid cells

R. Khan, J. Schmidt-Mende, M. Karimi, A.-M. Forsblom, V. Gogvadze, M. Hassan, T.J. Ekström, B. Zhivotovsky, E. Hellström-Lindberg

Journal:

Leukemia Research

Year:

2007

Language:

english

File:

PDF, 65 KB

english, 2007

23

P136 Treatment with erythropoietin and G-CSF improves survival in MDS patients with low transfusion need

M. Jädersten, L. Malcovati, I. Dybedal, M.G. Della Porta, R. Invernizzi, S.M. Montgomery, C. Pascutto, A. Porwit-MacDonald, M. Cazzola, E. Hellström-Lindberg

Journal:

Leukemia Research

Year:

2007

Language:

english

File:

PDF, 166 KB

english, 2007

24

OP20 Low-risk MDS – do we need more than suportive care?

E. Hellstrom-Lindberg

Journal:

Leukemia Research

Year:

2007

Language:

english

File:

PDF, 73 KB

english, 2007

25

37 Low-risk MDS; transfusion therapy, growth factors and the European view on lenalidomide

E. Hellström-Lindberg

Journal:

Leukemia Research

Year:

2009

Language:

english

File:

PDF, 52 KB

english, 2009

26

C014 Expression of p53 or cytoplasmic nucleophosmine associated with increased risk of disease progression in myelodysplastic syndrome with isolated del(5q)

M. Jadersten, L. Saft, H. Garelius, R. Hast, L. Nilsson, J. Samuelsson, A. Porwit, E. Hellström-Lindberg

Journal:

Leukemia Research

Year:

2009

Language:

english

File:

PDF, 65 KB

english, 2009

27

C028 Lenalidomide abrogates the clonal advantage of del(5q) MDS stem cells via alteration of niche interactions

C. Scharenberg, M. Jadersten, J. Palmquist, L. Forsblom, M. Jansson, E. Hellström-Lindberg

Journal:

Leukemia Research

Year:

2009

Language:

english

File:

PDF, 46 KB

english, 2009

28

P015 European LeukemiaNet registry programme for low/INT-1 IPSS score myelodysplastic syndromes

D. Bowen, J. Droste, A. Smith, P. Fenaux, A. Symeonidis, G. Sanz, E. Hellström-Lindberg, J. Cermak, R. Gologan, U. Germing, R. Stauder, L. Malcovati, T. de Witte

Journal:

Leukemia Research

Year:

2009

Language:

english

File:

PDF, 58 KB

english, 2009

29

YI1 Gene expression profiling of day 7 erythroblasts from refractory anemia with ringed sideroblasts (RARS) and microarray-based identification of erythroid granulocyte-CSF (G-CSF) targets

M. Nikpour, A. Pellagatti, A. Liu, M. Karimi, L. Malcovati, A.-M. Forsblom, V. Gogvadze, J.S. Wainscoat, M. Cazzola, B. Zhivotovsky, A. Grandien, J. Boultwood, E. Hellström-Lindberg

Journal:

Leukemia Research

Year:

2009

Language:

english

File:

PDF, 42 KB

english, 2009

30

P128 Transfusion independence (TI) in patients with myelodysplastic syndromes (MDS) treated with azacitidine (AZA)

L. Silverman, P. Fenaux, V. Santini, J. Seymour, G. Mufti, E. Hellström-Lindberg, A. Giagounidis, G. Sanz, J. Bennett, J. Backstrom, D. McKenzie, C. Beach

Journal:

Leukemia Research

Year:

2009

Language:

english

File:

PDF, 60 KB

english, 2009

31

P127 Rates of infection and bleeding are not increased in patients (Pts) with MDS treated with azacitidine (AZA) compared with best supportive care (BSC)

V. Santini, L. Silverman, J. Seymour, P. Fenaux, G. Mufti, E. Hellström-Lindberg, G. Sanz, C. Finelli, J. Backstom, D. McKenzie, C. Beach

Journal:

Leukemia Research

Year:

2009

Language:

english

File:

PDF, 46 KB

english, 2009

32

7 Management of 1000 patients with low- and intermediate-1 risk myelodysplastic syndromes in the European LeukemiaNet MDS Registry

L. de Swart, A. Smith, P. Fenaux, A. Symeonidis, E. Hellström-Lindberg, G. Sanz, J. Cermak, O. Georgescu, U. Germing, M. MacKenzie, O. Beyne-Rauzy, L. Malcovati, R. Stauder, J. Droste, D. Bowen, T. de

Journal:

Leukemia Research

Year:

2011

Language:

english

File:

PDF, 54 KB

english, 2011

33

34 Health-related quality of life in low-risk MDS patients from the European LeukemiaNet Registry: Correlation with age, gender and decreased survival

R. Stauder, A. Smith, T. de Witte, J. Proste, P. Fenaux, A. Symeonidis, E. Hellstrom-Lindberg, G. Sanz, J. Cermak, O. Georgescu, U. Germing, M. Mac Kenzie, O. Beyne-Rauzy, L. Malcovati, D. Bowen

Journal:

Leukemia Research

Year:

2011

Language:

english

File:

PDF, 55 KB

english, 2011

34

49 ABCB7 plays an essential role in sideroblast formation in acquired refractory anemia with ring sideroblasts

M. Nikpour, A. Liu, C. Scharenberg, K. Högstrand, S. Conte, M. Jansson, A.-M. Forsblom, A. Grandien, E. Hellström-Lindberg

Journal:

Leukemia Research

Year:

2011

Language:

english

File:

PDF, 71 KB

english, 2011

35

69 Hypomethylation of a non-coding RNA on chromosome 5q31.1 is a positive prognostic factor for survival in AML/high risk MDS

M.B. Treppendahl, X. Qiu, A. Soegaard, C. Hother, M.K. Andersen, L. Kjeldsen, L. Möllgaard, E. Hellström-Lindberg, P. Jones, G. Liang, K. Grønbæk

Journal:

Leukemia Research

Year:

2011

Language:

english

File:

PDF, 52 KB

english, 2011

36

58 Interaction of karyotype complexity and response on overall survival and AML progression in lenalidomide-treated Low/INT-1 risk del (5q) MDS patients

A. Giagounidis, E. Hellström-Lindberg, P. Fenaux, J. Backstrom, T. Fu, A. List

Journal:

Leukemia Research

Year:

2011

Language:

english

File:

PDF, 149 KB

english, 2011

37

135 Lower bone marrow myeloid and plasmacytoid dendritic cell counts in high-risk than in low-risk MDS patients and controls

L. Saft, E. Björklund, E. Hellström-Lindberg, A. Porwit

Journal:

Leukemia Research

Year:

2011

Language:

english

File:

PDF, 54 KB

english, 2011

38

171 Complex effects of azacitidine in primary myelodysplastic and normal bone marrow cell cultures

M. Grövdal, M. Karimi, M. Nikpour, L. McGovern, M. Jansson, A.-M. Forsblom, E. Hellström-Lindberg

Journal:

Leukemia Research

Year:

2011

Language:

english

File:

PDF, 56 KB

english, 2011

39

221 Occurrence of trisomy 8 (+8) in patients with Low- or Int-1-risk MDS with deletion 5q [del(5q)] treated with lenalidomide

G. Mufti, A. Giagounidis, B. Skikne, T. Fu, B. Schlegelberger, E. Hellström-Lindberg

Journal:

Leukemia Research

Year:

2011

Language:

english

File:

PDF, 54 KB

english, 2011

40

259 The clonal advantage of del(5q) MDS stem cells is mediated by increased adhesion to the microenvironment

C. Scharenberg, V. Giai, M. Jädersten, L. Forsblom, M. Jansson, E. Hellström-Lindberg

Journal:

Leukemia Research

Year:

2011

Language:

english

File:

PDF, 76 KB

english, 2011

41

296 Telomere shortening is associated with AML progression in patients with myelodysplastic syndrome and deletion 5q treated with lenalidomide

G. Göhring, K. Lange, W. Hofmann, H. Kreipe, E. Hellström-Lindberg, A. Giagounidis, B. Schlegelberger

Journal:

Leukemia Research

Year:

2011

Language:

english

File:

PDF, 54 KB

english, 2011

42

380 Characterisation and targeting of malignant stem cells in myelodysplastic syndromes

O. Chowdhury, P. Woll, J. Leonard, K. Anderson, T. Mizukami, A. Mead, E. Hellstrom-Lindberg, L. Nilsson, R. Callaghan, S.E. Jacobsen

Journal:

Leukemia Research

Year:

2011

Language:

english

File:

PDF, 54 KB

english, 2011

43

Erythroid response to treatment with G-CSF plus erythropoietin for the anaemia of patients with myelodysplastic syndromes: proposal for a predictive model

Eva Hellström-Lindberg, Robert Negrin, Richard Stein, Sanford Krantz, Greger Lindberg, James Vardiman, ÅKe ÖSt, Peter Greenberg

Journal:

British Journal of Haematology

Year:

1997

Language:

english

File:

PDF, 427 KB

english, 1997

44

Spontaneous and cytokine-induced thrombocytopenia in myelodysplastic syndromes: serum thrombopoietin levels and bone marrow morphology

Eva Hellström-Lindberg, Lena Kanter-Lewensohn, Janet Nichol, Åke Öst, for the Scandinavian MDS Group, Sweden, Norway

Journal:

British Journal of Haematology

Year:

1999

Language:

english

File:

PDF, 297 KB

english, 1999

45

A validated decision model for treating the anaemia of myelodysplastic syndromes with erythropoietin + granulocyte colony-stimulating factor: significant effects on quality of life

Eva Hellström-Lindberg, Nina Gulbrandsen, Greger Lindberg, Tomas Ahlgren, Inger Marie S. Dahl, Ingunn Dybedal, Gunnar Grimfors, Eva Hesse-Sundin, Martin Hjorth, Lena Kanter-Lewensohn, Olle Linder, Mic

Journal:

British Journal of Haematology

Year:

2003

Language:

english

File:

PDF, 214 KB

english, 2003

46

Sixth International Symposium on Myelodysplastic Syndromes, Stockholm, June 14–17, 2001

Eva Hellström-Lindberg

Journal:

International Journal of Hematology

Year:

2002

Language:

english

File:

PDF, 50 KB

english, 2002

47

Patients with del(5q) MDS who fail to achieve sustained erythroid or cytogenetic remission after treatment with lenalidomide have an increased risk for clonal evolution and AML progression

Gudrun Göhring, Aristoteles Giagounidis, Guntram Büsche, Hans Heinrich Kreipe, Martin Zimmermann, Eva Hellström-Lindberg, Carlo Aul, Brigitte Schlegelberger

Journal:

Annals of Hematology

Year:

2010

Language:

english

File:

PDF, 280 KB

english, 2010

48

Lead poisoning from souvenir earthenware

Eva Hellström-Lindberg, Andreas Björklund, Christine Karlson-Stiber, Pauline Harper, Anders I. Seldén

Journal:

International Archives of Occupational and Environmental Health

Year:

2006

Language:

english

File:

PDF, 203 KB

english, 2006

49

O-49 Management of the anemia of MDS

E. Hellström-Lindberg

Journal:

Leukemia Research

Year:

2005

Language:

english

File:

PDF, 160 KB

english, 2005

50

Haploinsufficiency of RPS14 in 5q− syndrome is associated with deregulation of ribosomal- and translation-related genes

Andrea Pellagatti, Eva Hellström-Lindberg, Aristoteles Giagounidis, Janet Perry, Luca Malcovati, Matteo G. Della Porta, Martin Jädersten, Sally Killick, Carrie Fidler, Mario Cazzola, James S. Wainscoa

Journal:

British Journal of Haematology

Year:

2008

Language:

english

File:

PDF, 360 KB

english, 2008